TABLE 4.

Effect of patient characteristics on LOS by univariate analysis

Variable (no. of patients no/no. of patients yes)Median ± SD (range) LOS (days)P valuea
NoYes
Resistant pathogen (469/193)31 ± 38.75 (1-270)36 ± 42.96 (1-278)0.0060
MDR pathogen (559/103)30 ± 37.69 (1-270)47 ± 49.00 (1-278)<0.0001
ICU stay (164/498)8 ± 14.66 (1-101)42 ± 40.92 (2-287)<0.0001
Gender (244/417)31 ± 37.22 (1-206)34 ± 42.21 (1-278)0.2066
Age < 1 yr (439/166)26 ± 31.53 (1-206)58 ± 49.95 (3-278)<0.0001
Age ≥1 but <12 yr (582/23)33 ± 40.64 (1-278)21 ± 40.58 (5-147)0.2715
Age ≥ 12 yr (189/416)52 ± 49.85 (3-278)26.5 ± 31.00 (1-206)<0.0001
BSI (452/210)29.5 ± 39.12 (1-278)38.5 ± 41.52 (1-216)<0.0001
Pneumonia (437/225)24 ± 37.20 (1-216)43 ± 42.99 (7-278)<0.0001
SSI (484/178)42 ± 41.38 (1-278)10 ± 21.27 (1-137)<0.0001
Otherb (613/48)31 ± 40.43 (1-278)47 ± 32.18 (1-121)0.0239
Central venous line (517/145)31 ± 40.83 (1-278)37 ± 37.72 (1-206)0.0408
Chemotherapy (650/12)33 ± 40.36 (1-278)14 ± 18.25 (1-48)0.0185
Foley catheter (648/14)32 ± 40.40 (1-278)52.5 ± 25.80 (15-101)0.0183
Neutropenia (652/10)32.5 ± 40.41 (1-278)37.5 ± 17.72 (4-61)0.8742
TPN (584/78)30 ± 37.33 (1-270)58.5 ± 50.38 (7-278)<0.0001
Transplantation (658/4)32 ± 39.81 (1-278)101 ± 63.71 (34-168)0.0331
Ventilator (441/221)24 ± 37.04 (1-216)43 ± 43.29 (7-278)<0.0001
  • a Significance was determined at the 0.05 level.

  • b Other includes UTIs.